Medigene AG (MDG1) — Capital Reinvestment Ratio
Latest as of June 2022:
0.01x
Medigene AG (MDG1) has a Capital Reinvestment Ratio of 0.01x as of June 2022, meaning it reinvests 0% of its operating cash flow (€17.30 Million) in capital expenditures (€230.00K). See Medigene AG (MDG1) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
€17.30 Million
EUR
Capital Expenditures
€230.00K
EUR
Data as of
Jun 2022
Most recent filing
Medigene AG Capital Reinvestment Ratio (2011–2022)
This chart tracks Medigene AG's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Medigene AG (2011–2022)
Year-by-year Capital Reinvestment Ratio for Medigene AG from 2011 to 2022. For live market cap and broader valuation context, see Medigene AG market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.08x | €11.98 Million | €1.01 Million | ▲ +42.2% |
| 2011 | 0.06x | €6.86 Million | €406.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow